BiotechTube
Invicon Diagnostic Concepts

Invicon Diagnostic Concepts

Berlin, Germany· Est.
invicon.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.5M

Overview

Invicon Diagnostic Concepts is a specialized provider of in-vitro diagnostic (IVD) quality control solutions, serving clinical laboratories primarily in Germany and Switzerland. The company's core business revolves around manufacturing and distributing lyophilized and liquid control materials under brands like invitrol® and through partnerships, such as with SERO and UTAK, to offer a comprehensive QC portfolio. It differentiates itself through a strong customer service model, ISO 13485-certified quality management, and a proprietary 'Select Control' tool for creating customized, cost-efficient QC concepts for laboratories. As a private company, it operates in the established but competitive niche of diagnostic QC, focusing on reliability and regulatory compliance.

Diagnostics

Technology Platform

Expertise in formulation, stabilization, and value assignment of biological/synthetic quality control materials for clinical diagnostics. Platform includes lyophilization technology, specialty matrix development, and a proprietary software tool (Select Control) for customized QC planning.

Funding History

2
Total raised:$10.5M
Series A$8M
Seed$2.5M

Opportunities

Growth is driven by increasing global demand for laboratory accreditation (requiring third-party controls) and the expansion of complex test menus in areas like immunochemistry and toxicology.
Geographic expansion within the EU, facilitated by new regulatory registrations, presents a clear opportunity for market penetration beyond the DACH region.

Risk Factors

Key risks include intense competition from larger global QC manufacturers and instrument vendors, significant regulatory challenges and costs associated with the new EU IVDR, and pricing pressure from consolidating laboratory customers.
Technological shifts towards integrated lab automation could pose a long-term threat.

Competitive Landscape

Invicon competes in the niche but competitive market for third-party diagnostic QC materials. Major competitors include global giants like Bio-Rad and Randox, as well as the in-house control solutions provided by large IVD instrument manufacturers (Roche, Abbott, Siemens). Invicon's differentiation lies in its focused portfolio, high-touch customer service, and customization capabilities for the German-speaking market.

More companies in Diagnostics & Precision Medicine →More companies in Germany →